Center of Internal Medicine and Dermatology, Division of PsychoNeuroImmunology, Charité, University Medicine Berlin, Berlin, Germany.
J Reprod Immunol. 2009 Jun;80(1-2):80-90. doi: 10.1016/j.jri.2008.12.005. Epub 2009 Apr 18.
Endometriosis is a widespread chronic disease characterized by endometrial tissue located outside the uterine cavity. Clinical signs are chronic pelvic pain and infertility. Emerging evidence indicates that the immune system is profoundly involved in the onset and/or progression of endometriosis. However, mechanistic pathways have not yet been conclusively specified. In this study, women undergoing diagnostic laparoscopy due to infertility were recruited, and classified as early-stage endometriosis (n=30), advanced-stage endometriosis (n=8) or no endometriosis (n=31). The frequency and phenotype of leukocytes were evaluated in peritoneal fluid. While the frequency of lymphocytes was not significantly different, neutrophils were increased in endometriosis. Flow cytometry analysis revealed an increased frequency of CD4(+) and CD8(+) cells in peritoneal fluid of endometriosis patients. In addition, the frequency of CD4(+)CD25(+)CD103(+) cells and lineage(-)HLA-DR(+)CD11c(+)CD123(+) dendritic cells was decreased in peritoneal fluid in endometriosis, whereas CD57(+) NK cells and CD8(+)CD28(-) T suppressor cells remained largely unaltered. We conclude that therapeutic approaches in endometriosis might focus on peritoneal leukocytes as a target or surveillance marker; however, immune alterations in peritoneal fluid are subtle and their analysis will require highly standardized and harmonized protocols.
子宫内膜异位症是一种广泛存在的慢性疾病,其特征是子宫内膜组织位于子宫腔外。其临床症状为慢性盆腔疼痛和不孕。新出现的证据表明,免疫系统在子宫内膜异位症的发生和/或进展中起着重要作用。然而,其具体的作用机制尚未明确。在这项研究中,我们招募了因不孕而接受诊断性腹腔镜检查的女性,并将其分为早期子宫内膜异位症(n=30)、晚期子宫内膜异位症(n=8)或无子宫内膜异位症(n=31)。评估了腹腔液中白细胞的频率和表型。虽然淋巴细胞的频率没有显著差异,但子宫内膜异位症患者的中性粒细胞增加。流式细胞术分析显示,子宫内膜异位症患者腹腔液中 CD4(+)和 CD8(+)细胞的频率增加。此外,腹腔液中 CD4(+)CD25(+)CD103(+)细胞和谱系阴性 HLA-DR(+)CD11c(+)CD123(+)树突状细胞的频率降低,而 CD57(+)NK 细胞和 CD8(+)CD28(-)T 抑制细胞基本不变。我们得出结论,子宫内膜异位症的治疗方法可能集中在腹腔白细胞作为靶点或监测标志物上;然而,腹腔液中的免疫改变是微妙的,其分析需要高度标准化和协调的方案。